1. A message from the new editor-in-chief

   • Yasumasa Nishimura

   Editorial 07 April 2020 Pages: 785 - 786

   

2. Toward a new stage of PD-1 blockade cancer immunotherapy

   • Nagahiro Minato

   Introduction to Review Articles 16 March 2020 Pages: 787 - 789

3. Current issues and perspectives in PD-1 blockade cancer immunotherapy

   • Kenji Chamoto
   • Ryusuke Hatae
   • Tasuku Honjo

   Invited Review Article Open access 03 January 2020 Pages: 790 - 800

   

4. Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment

   • Hiro Sato
   • Noriyuki Okonogi
   • Takashi Nakano

   Invited Review Article Open access 03 April 2020 Pages: 801 - 809

   

5. Immune-resistant mechanisms in cancer immunotherapy

   • Yutaka Kawakami
   • Shigeki Ohta
   • Tomonori Yaguchi

   Invited Review Article 09 January 2020 Pages: 810 - 817

   

6. Combination therapy with PD-1 or PD-L1 inhibitors for cancer

   • Hidetoshi Hayashi
   • Kazuhiko Nakagawa

   Invited Review Article 23 September 2019 Pages: 818 - 830

7. Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology

   • Ryoichi Saito
   • Takashi Kobayashi
   • Osamu Ogawa

   Invited Review Article 12 August 2019 Pages: 831 - 841

   

8. Treatment strategies for neuroendocrine carcinoma of the upper digestive tract

   • Masaru Morita
   • Kenichi Taguchi
   • Yasushi Toh

   Original Article 08 February 2020 Pages: 842 - 850

   

9. Magnitude of advantage in tumor response contributes to a better correlation between treatment effects on overall survival and progression-free survival: a literature-based meta-analysis of clinical trials in patients with metastatic colorectal cancer

   • Yosuke Yoshida
   • Masayuki Kaneko
   • Mamoru Narukawa

   Original Article 16 January 2020 Pages: 851 - 860

   

10. Treatment choices and outcomes of non-metastatic hepatocellular carcinoma patients in relationship to neighborhood socioeconomic status: a population-based study

    • Omar Abdel-Rahman

    Original Article 18 January 2020 Pages: 861 - 866

    

11. A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101-

    • Takashi Kasai
    • Kiyoshi Mori
    • for The Tokyo Cooperative Oncology Group

    Original Article 14 February 2020 Pages: 867 - 875

    

12. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma

    • Naoki Ozeki
    • Koji Kawaguchi
    • Toyofumi Fengshi Chen-Yoshikawa

    Original Article 18 January 2020 Pages: 876 - 884

    

13. Lung cancer incidence and mortality in relationship to hormone replacement therapy use among women participating in the PLCO trial: a post hoc analysis

    • Omar Abdel-Rahman

    Original Article 09 January 2020 Pages: 885 - 891

    

14. Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution

    • Toshio Takagi
    • Kazuhiko Yoshida
    • Kazunari Tanabe

    Original Article 11 February 2020 Pages: 892 - 898

    

15. Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice

    • Daichi Tamura
    • Noriaki Jinnouchi
    • Wataru Obara

    Original Article 07 January 2020 Pages: 899 - 905

    

16. Barriers for sperm cryopreservation in advanced germ cell tumor patients: a 20-year experience

    • Katsuhiro Ito
    • Kentaro Ichioka
    • Hiromitsu Negoro

    Original Article 01 January 2020 Pages: 906 - 911

    

17. Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan

    • Shintaro Narita
    • Shingo Hatakeyama
    • Tomonori Habuchi

    Original Article 09 January 2020 Pages: 912 - 920

    

18. Outcome of patients with primary retroperitoneal solitary fibrous sarcoma

    • Peng Luo
    • Zhiqiang Wu
    • Chunmeng Wang

    Original Article 05 March 2020 Pages: 921 - 928

    

19. Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departments

    • Naoto Sassa
    • Yukihiro Yokoyama
    • Momokazu Gotoh

    Original Article 16 January 2020 Pages: 929 - 936

    

20. Laparoscopic versus abdominal radical hysterectomy for stage IB1 cervical cancer patients with tumor size ≤ 2 cm: a case-matched control study

    • Chunlin Chen
    • Ping Liu
    • Jinghe Lang

    Original Article 15 February 2020 Pages: 937 - 947

    

21. Operation for locally advanced cervical cancer after concurrent chemoradiotherapy

    • Junli Ge
    • Jidong Sun
    • Biliang Chen

    Original Article 31 March 2020 Pages: 948 - 954

    

22. Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study

    • Ayumi Taguchi
    • Akiko Furusawa
    • Toshiharu Yasugi

    Original Article 20 January 2020 Pages: 955 - 962

    

23. Risk factors for lower limb lymphedema in gynecologic cancer patients after initial treatment

    • Teruyo Kunitake
    • Tatsuyuki Kakuma
    • Kimio Ushijima

    Original Article Open access 06 January 2020 Pages: 963 - 971

    

24. Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma

    • Motoo Nomura
    • Isao Oze
    • Masashi Andoh

    Original Article 14 January 2020 Pages: 972 - 977

    

25. Safety of radiotherapy for hemodialysis patients with cancer

    • Hiroshi Hirota
    • Kei Ito
    • Ryouichi Yoshimura

    Original Article 21 January 2020 Pages: 978 - 983

    

26. High-grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

    • Joey Wee-Shan Tan
    • Grace Hwei Ching Tan
    • Melissa Ching Ching Teo

    Original Article 08 January 2020 Pages: 984 - 994